BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20074631)

  • 1. Effect of Eriochrome Black T on the gelatinization of xyloglucan investigated using rheological measurement and release behavior of Eriochrome Black T from xyloglucan gel matrices.
    Hirun N; Tantishaiyakul V; Pichayakorn W
    Int J Pharm; 2010 Mar; 388(1-2):196-201. PubMed ID: 20074631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAXS and ATR-FTIR studies on EBT-TSX mixtures in their sol-gel phases.
    Hirun N; Rugmai S; Sangfai T; Tantishaiyakul V
    Int J Biol Macromol; 2012 Nov; 51(4):423-30. PubMed ID: 22652217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelation of xyloglucan by addition of epigallocatechin gallate as studied by rheology and differential scanning calorimetry.
    Nitta Y; Fang Y; Takemasa M; Nishinari K
    Biomacromolecules; 2004; 5(4):1206-13. PubMed ID: 15244432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery.
    Mahajan HS; Tyagi V; Lohiya G; Nerkar P
    Drug Deliv; 2012; 19(5):270-6. PubMed ID: 22823894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
    Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of freeze-dried gallic acid/xyloglucan.
    Hirun N; Sangfai T; Tantishaiyakul V
    Drug Dev Ind Pharm; 2015 Feb; 41(2):194-200. PubMed ID: 24229065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery.
    Dilbaghi N; Kaur H; Ahuja M; Kumar S
    Carbohydr Polym; 2013 Apr; 94(1):286-91. PubMed ID: 23544540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physico chemical properties of aminated tamarind xyloglucan.
    Simi CK; Abraham TE
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):513-20. PubMed ID: 20817420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate.
    Avachat AM; Gujar KN; Wagh KV
    Carbohydr Polym; 2013 Jan; 91(2):537-42. PubMed ID: 23121942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic gel formation of xyloglucan/gellan mixtures as sudied by rheology, DSC, and circular dichroism.
    Nitta Y; Kim BS; Nishinari K; Shirakawa M; Yamatoya K; Oomoto T; Asai I
    Biomacromolecules; 2003; 4(6):1654-60. PubMed ID: 14606892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution properties of the xyloglucan polymer from Afzelia africana.
    Ren Y; Picout DR; Ellis PR; Ross-Murphy SB
    Biomacromolecules; 2004; 5(6):2384-91. PubMed ID: 15530055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient and quasi-permanent networks in xyloglucan solutions.
    de Freitas RA; Spier VC; Sierakowski MR; Nicolai T; Benyahia L; Chassenieux C
    Carbohydr Polym; 2015 Sep; 129():216-23. PubMed ID: 26050908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of xyloglucan and xanthan investigated by rheology, differential scanning calorimetry, and NMR.
    Kim BS; Takemasa M; Nishinari K
    Biomacromolecules; 2006 Apr; 7(4):1223-30. PubMed ID: 16602742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of xyloglucan hydrogel as the biomedical sustained-release carriers.
    Chen D; Guo P; Chen S; Cao Y; Ji W; Lei X; Liu L; Zhao P; Wang R; Qi C; Liu Y; He H
    J Mater Sci Mater Med; 2012 Apr; 23(4):955-62. PubMed ID: 22354327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
    Miyazaki S; Kawasaki N; Endo K; Attwood D
    J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocomposites coated with xyloglucan for drug delivery: In vitro studies.
    Ribeiro C; Arizaga GG; Wypych F; Sierakowski MR
    Int J Pharm; 2009 Feb; 367(1-2):204-10. PubMed ID: 18938232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of extraction conditions on properties of seed xyloglucan.
    Kai KC; Petkowicz CL
    Int J Biol Macromol; 2010 Mar; 46(2):223-8. PubMed ID: 20060409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.